Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 33 | 2014 | 3781 | 1.260 |
Why?
|
Brain | 50 | 2020 | 27454 | 0.950 |
Why?
|
Huntington Disease | 18 | 2007 | 1147 | 0.870 |
Why?
|
Receptors, Dopamine | 5 | 2009 | 296 | 0.840 |
Why?
|
Basal Ganglia | 7 | 2013 | 555 | 0.810 |
Why?
|
Corpus Striatum | 19 | 2018 | 1237 | 0.800 |
Why?
|
Parkinsonian Disorders | 5 | 2015 | 285 | 0.770 |
Why?
|
Brain Chemistry | 7 | 2014 | 962 | 0.740 |
Why?
|
Magnetic Resonance Imaging | 56 | 2020 | 36849 | 0.730 |
Why?
|
Amphetamine | 10 | 2015 | 225 | 0.720 |
Why?
|
Receptors, Dopamine D3 | 4 | 2010 | 109 | 0.720 |
Why?
|
Cocaine | 10 | 2011 | 960 | 0.710 |
Why?
|
Dopamine | 13 | 2013 | 1617 | 0.630 |
Why?
|
Rats, Sprague-Dawley | 37 | 2018 | 8199 | 0.610 |
Why?
|
Neurodegenerative Diseases | 4 | 2015 | 1094 | 0.580 |
Why?
|
Ibuprofen | 4 | 2014 | 229 | 0.580 |
Why?
|
Cerebrovascular Circulation | 15 | 2011 | 2736 | 0.580 |
Why?
|
Neuropharmacology | 2 | 2014 | 20 | 0.570 |
Why?
|
Brain Mapping | 16 | 2018 | 6740 | 0.570 |
Why?
|
Receptors, Dopamine D2 | 5 | 2010 | 487 | 0.560 |
Why?
|
Dopamine Agonists | 6 | 2013 | 353 | 0.550 |
Why?
|
Methamphetamine | 2 | 2018 | 167 | 0.540 |
Why?
|
Dopamine Uptake Inhibitors | 10 | 2011 | 298 | 0.540 |
Why?
|
Inositol | 3 | 2013 | 216 | 0.510 |
Why?
|
Creatine | 7 | 2009 | 427 | 0.480 |
Why?
|
Housing, Animal | 1 | 2014 | 47 | 0.470 |
Why?
|
Neuroprotective Agents | 8 | 2019 | 957 | 0.450 |
Why?
|
Hemodynamics | 6 | 2012 | 4199 | 0.450 |
Why?
|
Alzheimer Disease | 11 | 2019 | 8747 | 0.450 |
Why?
|
Neural Pathways | 5 | 2018 | 3121 | 0.440 |
Why?
|
Disease Models, Animal | 27 | 2019 | 18362 | 0.420 |
Why?
|
Rats | 41 | 2015 | 23835 | 0.420 |
Why?
|
Dopamine Antagonists | 3 | 2013 | 289 | 0.410 |
Why?
|
Amyotrophic Lateral Sclerosis | 4 | 2014 | 1473 | 0.410 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2017 | 2276 | 0.400 |
Why?
|
Hippocampus | 7 | 2018 | 3784 | 0.390 |
Why?
|
Movement | 3 | 2007 | 1490 | 0.380 |
Why?
|
Transgenes | 1 | 2014 | 1015 | 0.370 |
Why?
|
Microdialysis | 6 | 2010 | 163 | 0.360 |
Why?
|
Motor Neurons | 3 | 2014 | 872 | 0.330 |
Why?
|
Receptors, Dopamine D1 | 2 | 2010 | 293 | 0.330 |
Why?
|
Glutamic Acid | 6 | 2022 | 1193 | 0.330 |
Why?
|
Mice, Transgenic | 20 | 2019 | 9562 | 0.320 |
Why?
|
Limbic System | 1 | 2011 | 423 | 0.320 |
Why?
|
Animals | 81 | 2019 | 169337 | 0.310 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2015 | 1248 | 0.300 |
Why?
|
Aspartic Acid | 7 | 2009 | 577 | 0.290 |
Why?
|
Thalamus | 2 | 2006 | 1050 | 0.280 |
Why?
|
Tomography, Emission-Computed | 8 | 2004 | 1126 | 0.270 |
Why?
|
Psychomotor Performance | 3 | 2007 | 1895 | 0.260 |
Why?
|
Behavior, Animal | 6 | 2013 | 1879 | 0.260 |
Why?
|
Somatosensory Cortex | 1 | 2010 | 516 | 0.260 |
Why?
|
Aging | 7 | 2014 | 8764 | 0.250 |
Why?
|
Tetrahydronaphthalenes | 3 | 2011 | 86 | 0.250 |
Why?
|
Theobromine | 1 | 2005 | 14 | 0.240 |
Why?
|
Motor Activity | 10 | 2015 | 2720 | 0.240 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2005 | 781 | 0.240 |
Why?
|
Ferric Compounds | 3 | 2005 | 379 | 0.240 |
Why?
|
Glutamine | 4 | 2013 | 578 | 0.240 |
Why?
|
Receptor, Adenosine A2A | 1 | 2005 | 129 | 0.230 |
Why?
|
Nicotinic Agonists | 1 | 2006 | 266 | 0.230 |
Why?
|
Flurbiprofen | 2 | 2013 | 21 | 0.230 |
Why?
|
Parkinson Disease, Secondary | 3 | 2003 | 122 | 0.220 |
Why?
|
Central Nervous System Stimulants | 3 | 2015 | 1181 | 0.210 |
Why?
|
Positron-Emission Tomography | 5 | 2015 | 6670 | 0.210 |
Why?
|
Regional Blood Flow | 5 | 2011 | 1502 | 0.210 |
Why?
|
Lactic Acid | 10 | 2004 | 1140 | 0.210 |
Why?
|
Functional Laterality | 3 | 2007 | 2268 | 0.200 |
Why?
|
Energy Metabolism | 12 | 2004 | 2906 | 0.200 |
Why?
|
Neurotoxins | 10 | 1998 | 241 | 0.200 |
Why?
|
Superoxide Dismutase | 4 | 2014 | 595 | 0.190 |
Why?
|
Nicotine | 1 | 2006 | 680 | 0.190 |
Why?
|
Hand | 2 | 2004 | 912 | 0.190 |
Why?
|
Trinucleotide Repeats | 2 | 2001 | 257 | 0.180 |
Why?
|
Dopamine Agents | 4 | 2007 | 190 | 0.180 |
Why?
|
Acetylcholine | 2 | 2017 | 629 | 0.180 |
Why?
|
Lactates | 11 | 1999 | 401 | 0.180 |
Why?
|
Cerebral Cortex | 6 | 2015 | 5831 | 0.180 |
Why?
|
gamma-Aminobutyric Acid | 7 | 2022 | 1143 | 0.180 |
Why?
|
Membrane Transport Proteins | 2 | 2005 | 1034 | 0.180 |
Why?
|
Neurons | 12 | 2005 | 9513 | 0.180 |
Why?
|
Glucose | 5 | 2022 | 4352 | 0.170 |
Why?
|
Amyloid beta-Peptides | 6 | 2019 | 3910 | 0.170 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2008 | 1114 | 0.170 |
Why?
|
Dystonic Disorders | 1 | 2004 | 354 | 0.170 |
Why?
|
Neostriatum | 7 | 2009 | 247 | 0.160 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 5 | 2009 | 89 | 0.160 |
Why?
|
Gyrus Cinguli | 2 | 2022 | 1137 | 0.160 |
Why?
|
Cell Transplantation | 2 | 2002 | 475 | 0.150 |
Why?
|
Quinpirole | 2 | 2010 | 32 | 0.150 |
Why?
|
Nerve Tissue Proteins | 5 | 2005 | 4414 | 0.150 |
Why?
|
Blood Volume | 4 | 2010 | 546 | 0.150 |
Why?
|
Flavones | 1 | 2018 | 66 | 0.150 |
Why?
|
Drug-Seeking Behavior | 1 | 2018 | 46 | 0.150 |
Why?
|
Cation Transport Proteins | 1 | 2020 | 326 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2015 | 10776 | 0.150 |
Why?
|
Dyskinesia, Drug-Induced | 2 | 2009 | 165 | 0.140 |
Why?
|
Persian Gulf Syndrome | 1 | 2017 | 48 | 0.140 |
Why?
|
Manganese | 1 | 2020 | 394 | 0.140 |
Why?
|
Dietary Supplements | 2 | 2010 | 3443 | 0.140 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 3712 | 0.140 |
Why?
|
Meglumine | 1 | 1997 | 144 | 0.140 |
Why?
|
Occipital Lobe | 3 | 1999 | 376 | 0.140 |
Why?
|
Drug Repositioning | 1 | 2019 | 244 | 0.140 |
Why?
|
Serum Albumin | 2 | 1991 | 676 | 0.140 |
Why?
|
Gadolinium DTPA | 2 | 2009 | 823 | 0.130 |
Why?
|
Mice | 22 | 2019 | 82017 | 0.130 |
Why?
|
Male | 58 | 2020 | 364902 | 0.130 |
Why?
|
Photic Stimulation | 2 | 1999 | 2004 | 0.130 |
Why?
|
Contrast Media | 7 | 2011 | 5336 | 0.120 |
Why?
|
Neural Inhibition | 2 | 2011 | 588 | 0.120 |
Why?
|
Locomotion | 1 | 2018 | 390 | 0.120 |
Why?
|
Conditioning, Classical | 1 | 2018 | 370 | 0.120 |
Why?
|
Propionates | 5 | 2004 | 180 | 0.120 |
Why?
|
Lipoxins | 1 | 2017 | 419 | 0.120 |
Why?
|
Protons | 4 | 2009 | 1112 | 0.120 |
Why?
|
Motor Cortex | 2 | 2011 | 1014 | 0.120 |
Why?
|
Exploratory Behavior | 1 | 2015 | 276 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 1997 | 648 | 0.110 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2015 | 196 | 0.110 |
Why?
|
Flavanones | 1 | 2014 | 75 | 0.110 |
Why?
|
Encephalitis | 1 | 2017 | 441 | 0.110 |
Why?
|
Macaca fascicularis | 6 | 2009 | 913 | 0.110 |
Why?
|
Cricetulus | 1 | 2015 | 813 | 0.110 |
Why?
|
Eicosapentaenoic Acid | 1 | 2017 | 563 | 0.110 |
Why?
|
Epilepsy | 2 | 1999 | 3326 | 0.110 |
Why?
|
Self Administration | 2 | 2011 | 388 | 0.110 |
Why?
|
Receptor, trkB | 1 | 2014 | 125 | 0.110 |
Why?
|
Light | 1 | 1999 | 1354 | 0.110 |
Why?
|
Neurochemistry | 2 | 2007 | 29 | 0.110 |
Why?
|
Malonates | 5 | 1998 | 43 | 0.100 |
Why?
|
CHO Cells | 1 | 2015 | 1380 | 0.100 |
Why?
|
Ubiquinone | 3 | 2002 | 183 | 0.100 |
Why?
|
Oxygen | 6 | 2007 | 4273 | 0.100 |
Why?
|
Blood Proteins | 1 | 1997 | 1186 | 0.100 |
Why?
|
Cricetinae | 1 | 2015 | 2423 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 1997 | 877 | 0.090 |
Why?
|
Levodopa | 2 | 2009 | 223 | 0.090 |
Why?
|
Dextroamphetamine | 2 | 2005 | 134 | 0.090 |
Why?
|
Nerve Degeneration | 7 | 2007 | 750 | 0.090 |
Why?
|
Fingers | 2 | 2007 | 512 | 0.090 |
Why?
|
Oxidopamine | 3 | 2002 | 173 | 0.090 |
Why?
|
Phenanthridines | 1 | 2010 | 51 | 0.090 |
Why?
|
Brain Diseases | 1 | 1999 | 1552 | 0.090 |
Why?
|
Drug Interactions | 2 | 2005 | 1420 | 0.090 |
Why?
|
Protein Binding | 4 | 2015 | 9343 | 0.090 |
Why?
|
Sympathectomy, Chemical | 2 | 2000 | 25 | 0.090 |
Why?
|
Reperfusion Injury | 1 | 1997 | 1033 | 0.090 |
Why?
|
tau Proteins | 2 | 2013 | 2143 | 0.090 |
Why?
|
Ligands | 4 | 2007 | 3283 | 0.090 |
Why?
|
Tetrahydroisoquinolines | 1 | 2010 | 81 | 0.090 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2010 | 419 | 0.090 |
Why?
|
Iron Chelating Agents | 1 | 1991 | 141 | 0.080 |
Why?
|
Humans | 51 | 2022 | 768393 | 0.080 |
Why?
|
Nitriles | 2 | 2015 | 984 | 0.080 |
Why?
|
Enzymes | 1 | 1991 | 254 | 0.080 |
Why?
|
Dyskinesias | 1 | 2009 | 79 | 0.080 |
Why?
|
Presenilin-1 | 2 | 2010 | 665 | 0.080 |
Why?
|
Antiparkinson Agents | 1 | 2009 | 184 | 0.080 |
Why?
|
Radioligand Assay | 2 | 2007 | 367 | 0.080 |
Why?
|
Metacarpus | 1 | 2007 | 37 | 0.080 |
Why?
|
Nucleic Acids | 1 | 1991 | 189 | 0.070 |
Why?
|
Blood-Brain Barrier | 2 | 2009 | 1033 | 0.070 |
Why?
|
Mitochondria | 5 | 2008 | 3675 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2014 | 1496 | 0.070 |
Why?
|
Spectrum Analysis | 1 | 2009 | 449 | 0.070 |
Why?
|
Pyridines | 4 | 2015 | 2889 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 461 | 0.070 |
Why?
|
Acetamides | 2 | 2015 | 260 | 0.070 |
Why?
|
Isotopes | 1 | 2007 | 125 | 0.070 |
Why?
|
Benzamides | 2 | 2010 | 1380 | 0.070 |
Why?
|
Visual Cortex | 3 | 1999 | 1112 | 0.070 |
Why?
|
Electroencephalography | 3 | 1999 | 6317 | 0.070 |
Why?
|
Poly dA-dT | 1 | 1986 | 8 | 0.070 |
Why?
|
Amygdala | 1 | 2014 | 1382 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1813 | 0.070 |
Why?
|
Spin Labels | 2 | 1998 | 339 | 0.070 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2008 | 361 | 0.060 |
Why?
|
Physical Conditioning, Animal | 1 | 2009 | 366 | 0.060 |
Why?
|
Salicylamides | 1 | 2005 | 33 | 0.060 |
Why?
|
Methylphenidate | 1 | 2010 | 491 | 0.060 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2005 | 69 | 0.060 |
Why?
|
Models, Neurological | 2 | 2013 | 1783 | 0.060 |
Why?
|
Deoxyguanosine | 1 | 2006 | 96 | 0.060 |
Why?
|
Oxides | 2 | 2004 | 403 | 0.060 |
Why?
|
Time Factors | 10 | 2009 | 40272 | 0.060 |
Why?
|
Parkinson Disease | 3 | 2008 | 2895 | 0.060 |
Why?
|
Polydeoxyribonucleotides | 1 | 1986 | 136 | 0.060 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2005 | 49 | 0.060 |
Why?
|
Linear Models | 2 | 2009 | 5878 | 0.060 |
Why?
|
Echo-Planar Imaging | 3 | 1999 | 669 | 0.060 |
Why?
|
Amides | 1 | 2007 | 452 | 0.060 |
Why?
|
1-Methyl-4-phenylpyridinium | 2 | 1996 | 34 | 0.060 |
Why?
|
Brain Ischemia | 4 | 2000 | 3008 | 0.060 |
Why?
|
Oxidative Stress | 7 | 2005 | 3139 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2006 | 489 | 0.060 |
Why?
|
Schizophrenia | 2 | 2020 | 6987 | 0.060 |
Why?
|
Creatinine | 2 | 2001 | 1915 | 0.060 |
Why?
|
Cerebral Infarction | 2 | 2000 | 975 | 0.060 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 327 | 0.050 |
Why?
|
Nitric Oxide Synthase | 2 | 1997 | 911 | 0.050 |
Why?
|
N-Methylaspartate | 4 | 2001 | 231 | 0.050 |
Why?
|
Task Performance and Analysis | 1 | 2007 | 771 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4677 | 0.050 |
Why?
|
Electric Stimulation | 1 | 2007 | 1743 | 0.050 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2022 | 72 | 0.050 |
Why?
|
Nucleic Acid Conformation | 1 | 1986 | 900 | 0.050 |
Why?
|
Female | 24 | 2020 | 397089 | 0.050 |
Why?
|
Adrenergic Agents | 2 | 2002 | 73 | 0.050 |
Why?
|
Ketones | 1 | 2022 | 182 | 0.050 |
Why?
|
Adult | 14 | 2022 | 223640 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2007 | 6241 | 0.050 |
Why?
|
Nitro Compounds | 5 | 2004 | 74 | 0.050 |
Why?
|
Choline | 3 | 2004 | 518 | 0.050 |
Why?
|
Astrocytes | 2 | 2019 | 1349 | 0.040 |
Why?
|
Memory Disorders | 1 | 2008 | 1203 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2001 | 375 | 0.040 |
Why?
|
Motor Neuron Disease | 1 | 2001 | 98 | 0.040 |
Why?
|
Tobacco Use Disorder | 1 | 2006 | 708 | 0.040 |
Why?
|
Sympatholytics | 1 | 2000 | 82 | 0.040 |
Why?
|
Metabolomics | 1 | 2010 | 1674 | 0.040 |
Why?
|
Apomorphine | 1 | 2000 | 150 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2015 | 9614 | 0.040 |
Why?
|
Neurotoxicity Syndromes | 1 | 2004 | 302 | 0.040 |
Why?
|
Cyclic N-Oxides | 2 | 1997 | 72 | 0.040 |
Why?
|
Image Enhancement | 3 | 2001 | 2894 | 0.040 |
Why?
|
Striatonigral Degeneration | 1 | 1999 | 13 | 0.040 |
Why?
|
Nitrogen Oxides | 2 | 1997 | 129 | 0.040 |
Why?
|
Reaction Time | 1 | 2006 | 2103 | 0.040 |
Why?
|
Stereotyped Behavior | 1 | 2000 | 135 | 0.040 |
Why?
|
Microglia | 2 | 2019 | 1374 | 0.040 |
Why?
|
Sulfonamides | 1 | 2009 | 1980 | 0.040 |
Why?
|
Toes | 1 | 2000 | 209 | 0.040 |
Why?
|
Maze Learning | 2 | 2013 | 484 | 0.040 |
Why?
|
Saccades | 1 | 2000 | 235 | 0.040 |
Why?
|
Oxidative Phosphorylation | 2 | 1999 | 501 | 0.040 |
Why?
|
Riluzole | 1 | 1999 | 61 | 0.040 |
Why?
|
Pyrazoles | 1 | 2009 | 2021 | 0.040 |
Why?
|
Iron | 2 | 2004 | 1814 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2862 | 0.040 |
Why?
|
DEET | 1 | 2017 | 10 | 0.040 |
Why?
|
Permethrin | 1 | 2017 | 15 | 0.040 |
Why?
|
Rotation | 1 | 2000 | 517 | 0.040 |
Why?
|
Hydrogen | 1 | 1999 | 171 | 0.040 |
Why?
|
Pyridostigmine Bromide | 1 | 2017 | 32 | 0.040 |
Why?
|
Carbon Radioisotopes | 2 | 2015 | 567 | 0.040 |
Why?
|
Synapses | 1 | 2007 | 1766 | 0.040 |
Why?
|
Models, Structural | 1 | 1998 | 340 | 0.040 |
Why?
|
Cell Count | 2 | 2014 | 1833 | 0.040 |
Why?
|
Iodoacetates | 1 | 1997 | 17 | 0.040 |
Why?
|
Nonlinear Dynamics | 1 | 2000 | 494 | 0.040 |
Why?
|
Reperfusion | 1 | 1998 | 266 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1100 | 0.040 |
Why?
|
Partial Pressure | 1 | 1997 | 248 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22355 | 0.030 |
Why?
|
Epilepsy, Generalized | 1 | 1999 | 181 | 0.030 |
Why?
|
Piperazines | 1 | 2007 | 2552 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1999 | 452 | 0.030 |
Why?
|
Gentisates | 1 | 1995 | 5 | 0.030 |
Why?
|
Electron Transport Complex II | 1 | 1996 | 53 | 0.030 |
Why?
|
Adenosine Triphosphate | 7 | 1998 | 2002 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 1997 | 9198 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2018 | 244 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2007 | 9063 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1674 | 0.030 |
Why?
|
Proteins | 1 | 1991 | 6006 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3541 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6318 | 0.030 |
Why?
|
Succinate Dehydrogenase | 1 | 1996 | 148 | 0.030 |
Why?
|
Magnetics | 1 | 1998 | 599 | 0.030 |
Why?
|
Biogenic Amines | 1 | 1994 | 53 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 1997 | 463 | 0.030 |
Why?
|
Dizocilpine Maleate | 4 | 1995 | 173 | 0.030 |
Why?
|
Azides | 1 | 1994 | 120 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 1995 | 229 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1995 | 213 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1996 | 412 | 0.030 |
Why?
|
Glycolysis | 1 | 1998 | 838 | 0.030 |
Why?
|
Body Weight | 4 | 2009 | 4629 | 0.030 |
Why?
|
Coenzymes | 3 | 2002 | 101 | 0.030 |
Why?
|
Spinal Cord | 2 | 2014 | 1813 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7599 | 0.030 |
Why?
|
Reference Values | 3 | 2001 | 4941 | 0.030 |
Why?
|
Middle Aged | 12 | 2010 | 223491 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1024 | 0.030 |
Why?
|
Silicones | 1 | 1994 | 228 | 0.030 |
Why?
|
Nerve Growth Factors | 1 | 1996 | 564 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1996 | 665 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1997 | 1149 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 424 | 0.030 |
Why?
|
Niacinamide | 1 | 1994 | 418 | 0.030 |
Why?
|
Artifacts | 2 | 2004 | 1930 | 0.020 |
Why?
|
Binding Sites | 2 | 1991 | 6017 | 0.020 |
Why?
|
Sensitivity and Specificity | 4 | 2004 | 14737 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 1996 | 607 | 0.020 |
Why?
|
Cattle | 1 | 1997 | 3826 | 0.020 |
Why?
|
Free Radicals | 3 | 1998 | 238 | 0.020 |
Why?
|
Nuclear Proteins | 3 | 2002 | 5800 | 0.020 |
Why?
|
Ferrosoferric Oxide | 2 | 2004 | 349 | 0.020 |
Why?
|
NADPH Dehydrogenase | 3 | 1997 | 44 | 0.020 |
Why?
|
Rabbits | 1 | 1997 | 4781 | 0.020 |
Why?
|
Adolescent | 3 | 2010 | 89184 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2593 | 0.020 |
Why?
|
Fluorine | 1 | 1991 | 83 | 0.020 |
Why?
|
Isomerism | 1 | 1991 | 198 | 0.020 |
Why?
|
Movement Disorders | 1 | 1995 | 464 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 523 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2007 | 4429 | 0.020 |
Why?
|
Phantoms, Imaging | 3 | 2010 | 2528 | 0.020 |
Why?
|
Edetic Acid | 1 | 1991 | 278 | 0.020 |
Why?
|
Synaptic Membranes | 1 | 2009 | 89 | 0.020 |
Why?
|
Prefrontal Cortex | 2 | 2011 | 2257 | 0.020 |
Why?
|
Presenilins | 1 | 2009 | 51 | 0.020 |
Why?
|
Cell Survival | 2 | 2014 | 5792 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2005 | 14784 | 0.020 |
Why?
|
Blood Glucose | 2 | 2001 | 6430 | 0.020 |
Why?
|
Bilirubin | 1 | 1991 | 438 | 0.020 |
Why?
|
Neuropeptides | 1 | 1994 | 950 | 0.020 |
Why?
|
Stem Cells | 1 | 2002 | 3539 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 905 | 0.020 |
Why?
|
Models, Chemical | 1 | 1991 | 611 | 0.020 |
Why?
|
Substance P | 3 | 1994 | 332 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 1990 | 423 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1991 | 1435 | 0.020 |
Why?
|
Extracellular Fluid | 1 | 2009 | 165 | 0.020 |
Why?
|
Macaca mulatta | 2 | 2011 | 2362 | 0.020 |
Why?
|
Language | 1 | 1997 | 1558 | 0.020 |
Why?
|
Body Water | 2 | 1999 | 340 | 0.020 |
Why?
|
Tryptophan | 1 | 1990 | 482 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2013 | 11120 | 0.020 |
Why?
|
Somatostatin | 3 | 1994 | 458 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 2007 | 417 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2009 | 321 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2007 | 438 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1994 | 1279 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11221 | 0.020 |
Why?
|
Nucleus Accumbens | 1 | 2009 | 373 | 0.020 |
Why?
|
Inflammation | 2 | 2017 | 10863 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 948 | 0.020 |
Why?
|
Atrophy | 2 | 2003 | 1648 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2007 | 612 | 0.020 |
Why?
|
Organ Size | 2 | 2002 | 2268 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3813 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11918 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2003 | 20224 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2000 | 1769 | 0.020 |
Why?
|
Blood Flow Velocity | 2 | 2001 | 1376 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2007 | 1142 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2734 | 0.020 |
Why?
|
Heart Rate | 1 | 1997 | 4218 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2009 | 1468 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5151 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2397 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1986 | 657 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 392 | 0.020 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 2 | 1994 | 63 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2003 | 22296 | 0.010 |
Why?
|
Homovanillic Acid | 2 | 1994 | 75 | 0.010 |
Why?
|
Water | 1 | 1991 | 1418 | 0.010 |
Why?
|
Gene Targeting | 1 | 2007 | 841 | 0.010 |
Why?
|
Spectrum Analysis, Raman | 1 | 1986 | 244 | 0.010 |
Why?
|
Memory | 1 | 2013 | 2210 | 0.010 |
Why?
|
Mammaplasty | 1 | 1994 | 1263 | 0.010 |
Why?
|
Succinic Acid | 1 | 2004 | 86 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 841 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2009 | 1175 | 0.010 |
Why?
|
Neuropeptide Y | 2 | 1994 | 194 | 0.010 |
Why?
|
Oxidation-Reduction | 3 | 1994 | 2225 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2009 | 1428 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2749 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 1991 | 1088 | 0.010 |
Why?
|
Age of Onset | 1 | 2009 | 3345 | 0.010 |
Why?
|
Electrophysiology | 2 | 1995 | 1266 | 0.010 |
Why?
|
Tyrosine | 2 | 1998 | 1428 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2017 | 4543 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1190 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 1994 | 559 | 0.010 |
Why?
|
Protein Conformation | 1 | 1990 | 3955 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3055 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1781 | 0.010 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2001 | 36 | 0.010 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2001 | 39 | 0.010 |
Why?
|
Blood Pressure | 1 | 1997 | 8541 | 0.010 |
Why?
|
Disease Progression | 3 | 2004 | 13646 | 0.010 |
Why?
|
Warfarin | 1 | 1990 | 1493 | 0.010 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2001 | 142 | 0.010 |
Why?
|
Dicarboxylic Acids | 1 | 2001 | 75 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1885 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14481 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1825 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 550 | 0.010 |
Why?
|
Pyrrolidines | 1 | 2001 | 340 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2000 | 753 | 0.010 |
Why?
|
Pentetic Acid | 1 | 1998 | 209 | 0.010 |
Why?
|
Chorea | 1 | 1999 | 80 | 0.010 |
Why?
|
Haplorhini | 1 | 1999 | 524 | 0.010 |
Why?
|
Mutation | 2 | 2008 | 30228 | 0.010 |
Why?
|
Fourier Analysis | 1 | 1999 | 440 | 0.010 |
Why?
|
Iodoacetic Acid | 1 | 1997 | 11 | 0.010 |
Why?
|
Dyslexia, Acquired | 1 | 1997 | 14 | 0.010 |
Why?
|
Drug Synergism | 1 | 2002 | 1762 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2001 | 567 | 0.010 |
Why?
|
Half-Life | 1 | 1998 | 650 | 0.010 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 79 | 0.010 |
Why?
|
Survival Rate | 2 | 2002 | 12870 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2003 | 1882 | 0.010 |
Why?
|
Phosphorylation | 1 | 2008 | 8326 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1339 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 65379 | 0.010 |
Why?
|
Biological Transport | 1 | 2001 | 2085 | 0.010 |
Why?
|
Neurotrophin 3 | 1 | 1996 | 61 | 0.010 |
Why?
|
Spin Trapping | 1 | 1995 | 4 | 0.010 |
Why?
|
Cognition | 1 | 2013 | 7075 | 0.010 |
Why?
|
Nanoparticles | 1 | 2007 | 1987 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1997 | 699 | 0.010 |
Why?
|
Dyslexia | 1 | 1997 | 215 | 0.010 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 70 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2004 | 2056 | 0.010 |
Why?
|
Hydroxyl Radical | 1 | 1995 | 82 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2000 | 1563 | 0.010 |
Why?
|
Quinolinic Acid | 1 | 1995 | 67 | 0.010 |
Why?
|
Sodium Azide | 1 | 1994 | 24 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1999 | 1585 | 0.010 |
Why?
|
Benzenesulfonates | 1 | 1995 | 165 | 0.010 |
Why?
|
Kainic Acid | 1 | 1995 | 203 | 0.010 |
Why?
|
Diffusion | 1 | 1997 | 818 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1998 | 13697 | 0.010 |
Why?
|
Coloring Agents | 1 | 1997 | 564 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2002 | 1667 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1994 | 413 | 0.010 |
Why?
|
Indazoles | 1 | 1995 | 305 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 4039 | 0.010 |
Why?
|
Putamen | 1 | 1995 | 293 | 0.010 |
Why?
|
Microinjections | 1 | 1994 | 323 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1755 | 0.010 |
Why?
|
Triazines | 1 | 1995 | 312 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7242 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15597 | 0.010 |
Why?
|
Molecular Biology | 1 | 1997 | 573 | 0.010 |
Why?
|
Japan | 1 | 1997 | 1418 | 0.010 |
Why?
|
Isoquinolines | 1 | 1994 | 354 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18471 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2001 | 1389 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1169 | 0.010 |
Why?
|
Electrochemistry | 1 | 1992 | 146 | 0.010 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 1993 | 263 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 12456 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2087 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1996 | 2695 | 0.010 |
Why?
|
Cell Death | 1 | 1995 | 1682 | 0.010 |
Why?
|
Radiography | 1 | 2000 | 6993 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9379 | 0.010 |
Why?
|
Interneurons | 1 | 1993 | 593 | 0.000 |
Why?
|
Neuronal Plasticity | 1 | 1997 | 1448 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1992 | 1539 | 0.000 |
Why?
|
Antihypertensive Agents | 1 | 1998 | 2027 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2001 | 3411 | 0.000 |
Why?
|
Nitric Oxide | 1 | 1997 | 2144 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6132 | 0.000 |
Why?
|
Antibodies | 1 | 1995 | 2425 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1998 | 3579 | 0.000 |
Why?
|
Insulin | 1 | 2001 | 6607 | 0.000 |
Why?
|
Signal Transduction | 1 | 2009 | 23631 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1997 | 5313 | 0.000 |
Why?
|
Pilot Projects | 1 | 1999 | 8731 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 4250 | 0.000 |
Why?
|
Alleles | 1 | 1995 | 6892 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 13423 | 0.000 |
Why?
|
Peptides | 1 | 1995 | 4353 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9493 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17626 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15939 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2001 | 39407 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1995 | 19022 | 0.000 |
Why?
|
Liver | 1 | 1994 | 7574 | 0.000 |
Why?
|
Prognosis | 1 | 1997 | 30022 | 0.000 |
Why?
|
Aged | 2 | 1999 | 171562 | 0.000 |
Why?
|